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Mouse natural killer T (NKT) cells expressing an in-
variant T cell antigen receptor (TCR) recognize glyco-
sphingolipids (GSLs) from Sphingomonas bacteria.
The synthetic antigens previously tested, however,
were designed to closely resemble the potent syn-
thetic agonist a-galactosyl ceramide (aGalCer),
which contains a monosaccharide and a C18:0
sphingosine lipid. Some Sphingomonas bacteria,
however, also have oligosaccharide-containing
GSLs, and they normally synthesize several GSLs
with different sphingosine chains including one with
a cyclopropyl ring-containing C21:0 (C21cycl) sphin-
gosine. Here we studied the stimulation of NKT cells
with synthetic GSL antigens containing natural tetra-
saccharide sugars, or the C21cycl sphingosine. Our
results indicate that there is a great degree of vari-
ability in the antigenic potency of different natural
Sphingomonas glycolipids, with the C21cycl sphin-
gosine having intermediate potency and the oligo-
saccharide-containing antigens exhibiting limited or
no stimulatory capacity.
INTRODUCTION
Natural killer T (NKT) cells are a sublineage of innate-like or nat-
ural memory T cells that share properties of both T lymphocytes
and NK cells (Bendelac et al., 2007; Godfrey and Berzins, 2007;
Kronenberg, 2005). More than 80% of mouse NKT cells express
an invariant (i) TCRa chain with Va14-Ja18 rearrangement. Here
we refer to these cells as Va14i NKT cells. Humans have a similar
population that mostly expresses an invariant Va24-Ja18 rear-
rangement (Va24i NKT cells). We refer to these populations in
mice and humans collectively as invariant NKT cells (iNKT cells).
iNKT cells participate in various immune responses through the
production of large amounts of cytokines. A role for these cells
has been reported in the response to tumors, the regulation of
autoimmunity, the pathogenesis of asthma and other inflamma-654 Chemistry & Biology 15, 654–664, July 21, 2008 ª2008 Elsevier Ltory conditions, and, most relevant for our studies, the response
to microbial infections (Bendelac et al., 2007; Brigl and Brenner,
2004; Godfrey and Berzins, 2007; Kronenberg, 2005; Tupin et al.,
2007).
iNKT cells recognize glycolipid antigens (Ags) bound to or pre-
sented by CD1d, an MHC class I-like antigen-presenting mole-
cule (Brigl and Brenner, 2004; Moody et al., 2005; Zajonc and
Kronenberg, 2007). The synthetic Ag a-galactosyl ceramide
(aGalCer) was the first known Ag presented by CD1d that could
stimulate the invariant TCR expressed by iNKT cells (Kawano
et al., 1997). aGalCer is a very close structural analog of several
agelasphins, compounds isolated from the Agelus genus of ma-
rine sponge (Morita et al., 1995). An unusual feature of this potent
GSL Ag is the a linkage of the sugar to the ceramide lipid, as most
other GSLs in nature were known to have a b linkage. Although
a number of synthetic antigens related to aGalCer were studied
to decipher structure-activity relationships (Tsuji, 2006), until re-
cently a microbial origin for iNKT cell antigen was not known.
Subsequently, Sphingomonas spp. bacteria were shown also
to have GSLs with a-linked hexose sugars and sphingoid bases
similar to the marine sponge agelasphins (Kawahara et al., 1991,
2002, 2006). Synthetic versions of these GSLs, with a-linked
monosaccharides, either galacturonic or glucuronic acid, and
a C18:0 sphingosine lipid, stimulated iNKT cells (Kinjo et al.,
2005; Mattner et al., 2005). The natural GSL Ags in Sphingomo-
nas spp. are much more heterogeneous, however, as a single
strain can produce more than one GSL and, furthermore, there
are differences between strains (Kawahara et al., 1991, 2000,
2001, 2002, 2006). There are variations not only in the complexity
and sequence of the a-linked sugars but also in the acyl chain
and sphingoid base of the ceramide lipid.
This study was designed to compare the antigenic potency of
the original synthetic GSL Ag we used, called GSL-1 here, with
other GSLs that represent some of the natural diversity found in
Sphingomonas spp. We synthesized and tested GSLs with two
different natural tetrasaccharide sugars and one with an unusual
C21 sphingoid base. In addition to antigenic stimulation, we de-
termined whether GSL Ags with more complex carbohydrates
are subject to antigen processing to generate monosaccha-
ride-containing GSLs, and whether these Ags can activate innate
immune responses by dendritic cells in the absence of iNKT cells.td All rights reserved
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Structures of the synthetic glycolipid antigens used in this study are depicted. The syntheses of GSL-4A, GSL-4Au, GSL-4Bu, and GalGSL-C21cycl(C21) are
described in this paper, whereas the syntheses of GSL-1, aGalCer, and aGal(1-2)aGalCer have been described previously, as indicated in the Experimental Pro-
cedures.RESULTS
Glycolipid Ag Structures
The GSL structures produced by different Sphingomonas spe-
cies are heterogeneous, and whereas some Sphingomonas bac-
teria only have GSL-1 Ags, containing monosaccharides, others
synthesize more complex sugars. Table S1, available online,
shows some of this antigenic diversity, including the GSLs
from several species that have been recently used for studies
of Va14i NKT cells (Supplemental Data). To determine whether
iNKT cells can recognize oligosaccharide-containing GSLs, we
synthesized GSLs with carbohydrate moieties corresponding
to the previously purified GSL-4A (Kawahara et al., 1991) and
GSL-4B Ags (Kawahara et al., 2001). For the ceramide lipid,
a C14 fatty acid was used for the Sphingomonas-related com-
pounds, because this is the observed length of the fatty acids
in the purified material. Variant forms with an unsaturated bond
in the sphingosine chain were prepared, and called GSL-4Au
(‘‘u’’ for unsaturation) and GSL-4Bu (Figure 1). These subtle
sphingosine alterations should not greatly alter the exposed car-
bohydrate epitope, and in fact for some experiments, the GSL-
4Au antigen was more potent than its fully saturated counterpart
(see below). For comparison, the structure of the highly potent
phytosphingosine-containing antigen aGalCer is also shown,Chemistry & Biology 15,along with a version of this Ag containing a second galactose
sugar (aGal(1-2)aGalCer) (Prigozy et al., 2001). The GSLs from
Sphingomonas bacteria contain different sphingosine chains,
including C18:0, C20:1, and a cyclopropyl-C21:0. To test how
these natural sphingosine variants affect Ag potency, we synthe-
sized a cyclopropyl-C21:0 chain containing a GSL with a single
a-linked galactose sugar (GalGSL-C21cycl).
Synthesis of GSL-4A, GSL-4Au, and GSL-4Bu
The synthesis of the GSL-4 glycosphingolipids relied on the
modular assembly of monosaccharide building blocks for the
formation of a tetrasaccharide glycosylating agent. Glycosyla-
tion of the sphingosine building block and global deprotection
steps resulted in the desired compounds. The assembly of
GSL-4A commenced with the glycosylation of the glucuronic
derivative 1 using the azidoglucose trichloroacetimidate 2
(Figure 2A). Galactosylating agent 4 formed an a-linkage with
high stereochemical control. The p-methoxybenzyl group was
removed by slowly raising the temperature to 0C. This one-
pot procedure furnished 5 in 57% overall yield. The last glycosyl-
ation provided fully protected tetrasaccharide 7 in excellent yield
and stereoselectivity. The tetrasaccharide glycosylating agent 8
was produced in good yield via a three-step procedure, palla-
dium-catalyzed isomerization of the allyl group and hydrolysis654–664, July 21, 2008 ª2008 Elsevier Ltd All rights reserved 655
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treatment with trichloroacetonitrile in the presence of catalytic
amounts of 1,8-diazabicyclo-[5.4.0]undec-7-ene (DBU). The gly-
cosylation of sphingosine building block 9 was tackled in the
subsequent step. The reaction was performed at low tempera-
ture in the presence of catalytic amounts of freshly distilled trime-
thylsilyl triflate (TMSOTf). The reactivity of 8 seemed low because
the product was obtained in modest yield, while most of the
glycosylating agent was recovered intact. Pure a anomer 10a
was isolated by standard silica gel and size-exclusion chroma-
tography.
The fully protected GSL-4A structures were readily obtained
by removal of the Boc group under acidic conditions and cou-
pling with myristic acid in the presence of N,N,N0,N0-tet-
ramethyl-O-(7-azabenzotriazol-1-yl)uronium hexafluorophos-
phate (HATU). Compound 11 was obtained in 92% yield over
two steps (Figure 2B).
Deprotection was achieved by saponification, followed either
by dissolving metal reduction or by palladium-catalyzed hydro-
genation. In the latter case, the removal of the benzyl groups
was performed with the concomitant reduction of the olefin at
the sphingosine moiety furnishing the product GSL-4Au. Birch
reaction conditions were chosen in order to keep the olefin intact
and obtain GSL-4A.
GSL-4Bu was generated in the same manner. The glucosyla-
tion of glucuronic acid building block 1 and deacetylation af-
forded disaccharide 14 in good yield (Figure 3A). Galactoside
15 proved to be an efficient glycosylating agent for the subse-
quent galactosylation, providing the desired trisaccharide in
good yield and selectivity. The appropriately protected trisac-
charide was converted to debenzoylated species 16 in excellent
overall yield. Glycosylation of the axial hydroxyl of 16 with
trichloroacetimidate 13 proved to be a highly selective transfor-
mation, leading to the desired a-linked product with excellent
diastereocontrol. Palladium-mediated deallylation and subse-
quent trichloroacetimidate formation led to the desired tetrasac-
charide glycosylating agent 18. Finally, coupling of the sphingo-
sine side chain and the tetrasaccharide in the presence of
a Lewis acid proceeded with high levels of stereoinduction to fur-
nish the desired a adduct. The modest yield of this particular
transformation may be attributed to severe steric crowding in
the transition state, as already observed for 10.
Compound 19 was further transformed into the final fully pro-
tected GSL-4Bu structure, as described previously for the GSL-
4A molecules. The tert-butoxycarbonyl group was cleaved under
acidic conditions, and the liberated amine was exposed to acyl-
ation conditions with myristic acid in the presence of HATU to
furnish 20 in good overall yield (Figure 3B). Hydrolysis of the es-
ters was performed in the presence of lithium peroxide, followed
by aqueous potassium hydroxide. The final benzyl ether cleav-
age was achieved in the presence of sodium and ammonia, af-
fording GSL-4Bu in acceptable yield over the three steps.Chemistry & Biology 15Synthesis of GalGSL-C21cycl
The synthesis of C21 began with the preparation of sphingoid
base 26 (Figure 4). For theSphingomonas glycolipids that contain
cyclopropanes in their sphingoid base, it is known that the alkyl
chains are cis. However, the absolute stereochemistries of the
cyclopropane stereogenic centers are unknown. Consequently,
we decided to prepare sphingoid base 26 with the absolute ste-
reochemistries of C2 and C3 set but with the cyclopropane hav-
ing defined relative, but not absolute, stereochemistry. Starting
with 10-undecyn-1-ol, silyl protection of the alcohol moiety, fol-
lowed by coupling of the terminal alkyne with 1-iodohexane
and hydrogenation over a Lindlar catalyst, afforded Z-alkene
21. Cyclopropanation (Charette et al., 2000) and deprotection
furnished cyclopropyl alcohol 22, which was converted to
Grignard reagent 23 by bromination and reaction with magne-
sium. The conversion of 23 to sphingoid base 26 utilized the
straightforward protocol we developed for the preparation of
sphinganines (So et al., 2004). Serine-derived Weinreb amide
24 (Campbell et al., 1998) was pretreated with two equivalents
of a sacrificial base, followed by the addition of 23, providing ke-
tone 25. Diastereoselective reduction, followed by carbamate
cleavage, gave 26. Although 26 was a mixture of diastereomers
due to cyclopropane stereoisomerism (relative, but not absolute,
stereochemistry set), spectroscopic characterization showed
only a single set of peaks (indicating that the cyclopropane moi-
ety was distant enough from C2 and C3 that its nonspecific ste-
reochemistry did not affect these centers). Sphinganine 26 was
coupled with activated ester 27 (the preparation of 27 is de-
scribed in the Supplemental Data), prepared as a single enantio-
mer from tetradecene by the protocol of Murakami et al. (2005).
The resultant ceramide was glycosylated with persilylated iodo-
sugar 29 under in situ anomerization conditions recently reported
by Gervay-Hague and colleagues (Du et al., 2007). The resultant
a-GalCer was treated with Dowex to cleave the silyl groups.
However, with repeated chromatographic purification, some am-
monium salt from the glycosylation remained. Rather than lose
more material, we elected to cleave the acetate group, and puri-
fication at this stage was successful, providing the C21 target.
Stimulation of Va14i NKT Cell Hybridomas
by Oligosaccharide GSL Ags
When presented by transfected B lymphoma cells expressing
a high number of surface CD1d molecules, GSL-4A could stim-
ulate IL-2 release from all three Va14i NKT cell hybridomas
tested. Each of these cells has an identical a chain of the TCR,
but two have different Vb8.2 rearrangements and one has
a Vb7 TCR (Figure 5). The responses induced by the GSL-4A
compound were much weaker than those induced by GSL-1.
For two hybridomas, 2C12 and 2H4, the response was stronger
to the GSL-4Au variant, with an unsaturated sphingosine base,
than to GSL-4A. Regardless, the data clearly establish that
GSL Ags containing this natural tetrasaccharide can stimulateFigure 2. The Synthesis of GSL-4 Compounds
(A) (a) (1) Azidoglucose 2, TMSOTf, toluene, 25C, 3 hr; (2) NaOMe, MeOH, rt, 15 hr, 91% (2 steps). (b) 4, TMSOTf, toluene, 50C to 0C, 2 hr, 57% (2 steps). (c)
6, TMSOTf, toluene, 0C, 1.5 hr, 75%. (d) (1) Pd(OAc)2, PPh3, MeOH, CH2Cl2, rt, 8 hr, 80%; (2) Cl3CCN, DBU, CH2Cl2, rt, 15 min, 76%. (e) 9, TMSOTf, toluene, Et2O
40C to 0C, 2 hr, 33% (a:b = 4:1).
(B) (a) (1) TFA, CH2Cl2, 0
C to rt, 2 hr; (2) myristic acid, HATU,N-methylmorpholine, CH2Cl2, 1,4-dioxane, rt, 18 hr, 92% (2 steps). (b) (1) H2O2, LiOH, MeOH/THF, rt,
15 hr; (2) KOH, MeOH/THF, rt, 15 hr, 99% (2 steps). (c) Na, NH3, THF, 78C, 45 min, 78%. (d) H2, Pd/C, MeOH, rt, 15 hr, 98%., 654–664, July 21, 2008 ª2008 Elsevier Ltd All rights reserved 657
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which has a different tetrasaccharide sugar, did not stimulate
any of the hybridomas.
Internalization and Lysosomal Ag Processing Are Not
Required for Va14i NKT Cell Stimulation by GSL-4A
Although the presentation of aGalCer by mouse CD1d (mCD1d)
does not absolutely require internalization, an analog of aGalCer,
aGal(1-2)aGalCer, which has an additional sugar (Figure 1), has
to be internalized in order to be efficiently recognized by Va14i
NKT cells. Internalized aGal(1-2)aGalCer is processed in lyso-
somes to remove the terminal galactose, generating the mono-
saccharide aGalCer (Prigozy et al., 2001). Similarly, it has been
reported that isoglobotrihexosyl ceramide (iGb3), an autologous
GSL Ag, must be processed in lysosomes from the nonantigenic
iGb4 for Va14i NKT cell activation (Zhou et al., 2004). To deter-
mine whether the weak antigenic activity of the GSL-4A com-
pounds depended upon internalization and processing, we
used antigen presenting cells (APC) that express a mutant
form of CD1d that does not traffic to lysosomes. The cytoplasmic
tail of mCD1d has a tyrosine-based endosomal targeting motif
responsible for mCD1d localization to lysosomes, where the
molecules are loaded with self- or exogenous antigens. Our
previous work showed that a single point mutation (I to A) in
the cytoplasmic tail motif could inhibit the translocation of
mCD1d to lysosomes, leading to impaired presentation of Ags
such as aGal(1-2)aGalCer that require lysosomal processing
(Lawton et al., 2005).
The ability of transfected A20 cells expressing the I/A cyto-
plasmic tail mutation of mCD1d to present the glycolipid Ag
aGal(1-2)aGalCer was compared to wild-type cells. We used
A20 transfectants that have similar amounts of surface mCD1d
molecules (Lawton et al., 2005). Consistent with our previous
work, cells expressing the I/A mutation could not stimulate IL-2
release by Va14i NKT cell hybridomas in response to aGal(1-
2)aGalCer, whereas wild-type mCD1d transfectants could
(Figure 6A). A20 cells expressing the CD1d (I/A) mutant were
comparable to cells expressing wild-type CD1d, however, in
their ability to present GSL-1. This is consistent with other data
indicating that monosaccharide GSL Ags have a reduced re-
quirement for lysosomal loading onto mCD1d. Interestingly, sim-
ilar to GSL-1, GSL-4Au also induced the same amount of IL-2 re-
lease with I/A mutant and wild-type mCD1d (Figure 6A). These
data suggest that lysosomal antigen processing is not required
for the weak stimulatory activity of a GSL Ag with a tetrasacchar-
ide sugar. Moreover, because wild-type mCD1d was not more
effective at presenting GSL-4, the data further suggest that Ag
processing does not efficiently generate the more potent mono-
saccharide.
To confirm that GSL-4 can stimulate Va14i NKT cell hybrid-
omas without lysosomal Ag processing, we tested these com-
pounds in an APC-free assay. Similar to the results obtained
with CD1d transfectants (Figure 5), GSL-4A and GSL-4Au could
stimulate Va14i NKT cell hybridomas when these compounds
were preincubated on mCD1d-coated microwells (Figure 6B).
GSL-4A was approximately equal to GSL-4Au for each hybrid-
oma tested, although it was slightly less potent when stimulating
hybridoma 2H4. By contrast, GSL-4A was slightly more potent
when stimulating hybridoma 1.2, which also reacted best to
GSL-4A when presented by CD1d-transfected APC. Consistent
with the results using transfected APC, GSL-4Bu could not stim-
ulate any of these three Va14i NKT cell hybridomas. These results
indicate that the invariant TCR of NKT cells can recognize some
tetrasaccharide-containing GSL Ags, even without lysosomal pro-
cessing in APC, to generate monosaccharide-containing GSLs.
GSL-4A and GSL-4B Do Not Directly Stimulate
Dendritic Cells
It was previously reported that GSL-4A purified from Sphingo-
monas paucimobilis stimulated an inflammatory cytokine
Figure 4. The Synthesis of GalGSL-C21
(C21)
(a) (1) tert-butyldimethylsilyl chloride, imidazole,
DMF, rt, 10 hr, 92%; (2) n-BuLi, THF, –10C,
10 min; hexamethylphosphoramide, iodohexane,
–10C to rt, 12 hr, 76%; (3) Pd/BaSO4, quinoline,
H2, THF, rt, 2 hr, 82%. (b) (1) Et2Zn, 2,4,6-trichlor-
ophenol, CH2Cl2, –40
C, 15 min; CH2I2, –40C to
rt, 12 hr, 90%; (2) TBAF, THF, 0C to rt, 2 hr,
89%. (c) (1) CBr4, PPh3, CH2Cl2, 0
C, quant.; (2)
Mg0, I2, THF. (d) i-PrMgCl (2 eq.), THF; 23 in THF,
–15C to rt, 51%. (e) (1) LiAl(Ot-Bu)3H, EtOH,
–78C, 5 hr, 83%; (2) 3 M HCl, MeOH, 50C, quant.
(f.) (1) Et3N, 80%. (g) (1) n-Bu4NI, (i-Pr)2EtN,
CH2Cl2; Dowex; (2) NaOMe, MeOH.Figure 3. The Synthesis of GSL-4 Compounds
(A) (a) (1) 13, TMSOTf, toluene, 40C to 25C, 1 hr, 96%; (2) NaOMe, MeOH, rt, 15 hr, 78%. (b) (1) 15, TMSOTf, CH2Cl2/Et2O, 60C to 20C, 1.5 hr; (2) H2O2,
LiOH, MeOH/THF, rt, 15 hr; (3) KOH, MeOH/THF, rt, 15 hr; (4) MeI, KHCO3, DMF, rt, 15 hr, 61% (4 steps). (c) 13, TMSOTf, toluene,40C to 0C, 1.5 hr, 39%. (d) (1)
Pd(OAc)2, PPh3, MeOH, CH2Cl2, rt, 24 hr; (2) Cl3CCN, DBU, CH2Cl2, rt, 1 hr, 48% (2 steps). (e) 9, TMSOTf, toluene, Et2O, 10C to rt, 3 hr, 13%.
(B) (a) (1) TFA, CH2Cl2, 0
C to rt, 2 hr; (2) myristic acid, HATU,N-methylmorpholine, CH2Cl2, 1,4-dioxane, rt, 18 hr, 73% (2 steps). (b) (1) H2O2, LiOH, MeOH/THF, rt,
15 hr; (2) KOH, MeOH/THF, rt, 15 hr; (3) Na, NH3, THF, 78C, 45 min, 45% (3 steps).Chemistry & Biology 15, 654–664, July 21, 2008 ª2008 Elsevier Ltd All rights reserved 659
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We tested whether synthetic GSL-4A and GSL-4B directly stim-
ulate mouse bone marrow-derived dendritic cells (DCs) by
stimulating toll-like receptor signaling. DCs were cultured with
GSL Ags, including GSL-1, GSL-4A, GSL-4Au, and GSL-4B, or
with LPS or CpG for 24 hr, and cytokines TNF (Figure S1A),
IL-12p70 (Figure S1B), and IL-12p40 (data not shown) were mea-
sured in the culture supernatant. GSL-4A and GSL-4B did not
induce the production of innate cytokines by DCs, although pos-
itive controls including LPS and CpG oligodeoxynucleotides
were effective (Figure S1). Furthermore, the expression of
CD40, CD80, and CD86 on DCs was not increased by the addi-
tion of GSL-4A or GSL-4B, although LPS and CpG did cause
increased expression of these surface molecules, indicative
of DC maturation (data not shown). These data show that
GSL-4 compounds do not directly stimulate mouse DCs for
Figure 5. Stimulation of Va14i NKT Cell
Hybridomas by Tetrasaccharide GSL Ags
Antigen presenting cells expressing mCD1d were
pulsed with the indicated amounts of synthetic
GSL compounds and then cultured with Va14i
NKT cell hybridomas 1.2 (top left), 2C12 (top right),
or 2H4 (bottom). IL-2 amounts measured in the
culture supernatant are shown. The error bars indi-
cate the SEM of triplicate measurements and the
data are representative of three separate experi-
ments.
Figure 6. Internalization and Ag Processing
Are Not Required for Stimulation of Va14i
NKT Cell Hybridomas by GSL-4A
(A) Antigen presenting cells expressing wild-type
mCD1d, designated A20/CD1d(WT), or cytoplas-
mic tail mutant mCD1d, A20/CD1d (I/A), were
pulsed with the indicated amounts of GSL com-
pounds and cultured with Va14i NKT hybridomas
2C12 (left) or 2H4 (right). GGC, aGal(1-2)aGalCer.
IL-2 amounts in the culture supernatant are
shown. The error bars indicate the SEM of tripli-
cate measurements and the data shown are repre-
sentative of three separate experiments.
(B) The indicated amounts (ng/well) of compounds
were incubated in wells coated with mCD1d. Stim-
ulation of Va14iNKT hybridomas 2C12 (left) or 2H4
(right) was determined by the production of IL-2 in
the culture supernatant. The error bars indicate the
SEM of triplicate measurements and the data
shown are representative of three separate exper-
iments. ND, not done.
maturation, activation, and the produc-
tion of inflammatory cytokines.
Va14i NKT Cell Activation by GSL
with an Altered Sphingosine
We also analyzed the antigenic potency
of a GSL Ag with a natural sphingosine
found in many Sphingomonas species
longer than the previously tested C18:0
sphingoid base. A synthetic GSL contain-
ing a linked galactose (GalGSL) and a ceramide with C14 fatty
acid, similar to the Sphingomonas lipid, and a cyclopropyl-
C21:0 chain sphingosine (GalGSL-C21cycl) was prepared and
analyzed. Figure 7A shows GalGSL-C21cycl was antigenic for
Va14i NKT hybridomas 1.2 and 2H4, and the stimulation was
dose dependent. Compared with aGalCer containing the identi-
cal carbohydrate moiety, however, GalGSL-C21cycl was
a weaker Ag, although it was more potent than galacturonic
acid-containing GSL-1.
We next tested whether GalGSL-C21cycl could stimulate
Va14i NKT cell hybridomas in an APC-free assay. GalGSL-
C21cycl could stimulate Va14i NKT cell hybridomas when this
compound was preincubated on mCD1d-coated microwells
(Figure 7B). These data indicate that lysosomal processing is
not required for responses to GalGSL-C21cycl, similar to
aGalCer and GSL-1. To determine whether GalGSL-C21cycl660 Chemistry & Biology 15, 654–664, July 21, 2008 ª2008 Elsevier Ltd All rights reserved
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and IFNg and IL-4 in the serum were measured. GalGSL-
C21cycl could induce a substantial amount of IFNg and IL-4 in
the sera of mice by only 2 hr after injection, although this re-
sponse was weaker than the response to aGalCer (Figure 7C).
The appearance of cytokines in the serum is an indication of sub-
stantial antigenic potency, however, as cytokines were not ob-
served with a number of glycolipid Ags, including GSL-4A
(data not shown).
DISCUSSION
The iNKT cell TCR recognizes glycolipid Ags presented by
CD1d. Until recently, however, the only Ags known to stimulate
most iNKT cells were aGalCer and closely related synthetic com-
pounds. Subsequently, it was shown that Sphingomonas bacte-
ria, which are abundant throughout the environment, also have
GSLs with a-linked sugars that are antigenic for iNKT cells.
Sphingomonas glycolipids are heterogeneous, however, not
only if different strains are compared, but in addition a single
strain can produce several glycolipids with structural variations
in the lipid, including the sphingosine base, as well as the sugar
(Kawahara et al., 1991, 2000, 2001, 2002, 2006). The Sphingo-
monas compounds tested in the first iNKT cell studies included
Figure 7. Antigenic Activity of GalGSL-
C21cycl (C21)
(A) Comparison of the Va14i NKT cell responses to
aGalCer, GSL-1, and GalGSL-C21cycl (C21) by
A20 transfectants expressing mCD1d. Antigen
presenting cells were pulsed with vehicle or the in-
dicated amounts of GSL compounds, and cul-
tured with Va14i NKT hybridomas 1.2 (left) or
2H4 (right). The error bars indicate the SEM of trip-
licate measurements.
(B) The indicated amounts (ng/well) of compounds
were incubated in wells coated with mCD1d. Stim-
ulation of Va14i NKT hybridomas, 1.2 (left) or 2H4
(right), was determined by the production of IL-2 in
the culture supernatant. The error bars indicate the
SEM of triplicate measurements and the data
shown are representative of three separate exper-
iments.
(C) Serum IFNg and IL-4 in mice treated with
GalGSL-C21cycl. Mice (five mice/group) were
injected intravenously with GalGSL-C21cycl
(10 mg) or aGalCer (1 mg), and serum IFNg and IL-4
was measured at 2 and 16 hr after injection. C21,
GalGSL-C21cycl; aGC, aGalCer. The data shown
are representative of two separate experiments.
purified material, likely to contain several
related GSLs, or synthetic versions of
Sphingomonas GSLs designed for maxi-
mum similarity to aGalCer. Therefore,
these synthetic compounds included
only the 18 carbon sphingosine base of
aGalCer, one of three sphingosine bases
typical for Sphingomonas spp. (Kawa-
hara et al., 1991, 2000, 2002, 2006), and
monosaccharide head groups, either gal-
acturonic or glucuronic acid (Kawahara et al., 2000, 2002, 2006).
As a consequence, it remained unknown whether the diverse
Sphingomonas glycolipids all have antigenic activity, and
whether some of those with more complex sugars require carbo-
hydrate antigen processing in order to be recognized by iNKT
cells. To determine whether these variant GSLs from Sphingo-
monas bacteria are Ags for iNKT cells, we chemically synthe-
sized antigens with tetrasaccharide head groups or with a C21
cyclopropyl sphingosine base and tested these for antigenic po-
tency.
Here we demonstrate that synthetic versions of the S. pauci-
mobilis tetrasaccharide-containing GSL-4A compounds are
weak antigens for Va14i NKT cell hybridomas, but a GSL-4B
compound related to Ags from S. adhaesiva was not antigenic.
Neither synthetic Ag could induce DC activation, although this
had been reported earlier for purified S. paucimobilis GSL-4A
(Kawahara et al., 2001), raising the possibility that some other
components in the purified material may have been responsible
for the earlier result. Whereas GSL-4A could induce IL-2 release
from all three Va14i NKT cell hybridomas tested, the responses
induced by these compounds were much weaker than the re-
sponse to the monosaccharide-containing GSL-1 antigen. IL-2
release by Va14i NKT cell hybridomas was observed in an
APC-free system, using CD1d-coated plates, demonstratingChemistry & Biology 15, 654–664, July 21, 2008 ª2008 Elsevier Ltd All rights reserved 661
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tionally, by comparing the response to APC-expressing wild-
type CD1d to the response induced by a CD1d protein bearing
a single point mutation (I to A) in the cytoplasmic tail that impairs
localization to lysosomes, we confirmed that carbohydrate anti-
gen processing did not significantly enhance the response to
GSL-4A, nor did it induce a response to GSL-4B.
Data from a previous report also suggested that purified
S. paucimobilis GSL-4A could induce a weaker response from
iNKT cells than a monosaccharide-containing GSL when fixed
APC were used to stimulate iNKT cell hybridomas (Sriram
et al., 2005). In data not shown, however, it was stated that the
response to GSL-4A was almost equivalent to a GSL containing
glucuronic acid as the monosaccharide head group (Sriram
et al., 2005). In our studies, by contrast, using either unfixed
APC, APC expressing a CD1d mutant for lysosomal trafficking,
or CD1d-coated plates, GSL-4A was a much weaker Ag than
GSL-1. For example, in the CD1d-coated plate assay, the lowest
dose of GSL-1 tested (125 ng/well) elicited significantly more
IL-2 release than 16-fold more GSL-4A. It is therefore
possible that minute amounts of contaminating GSL with
a monosaccharide head group could be responsible for the re-
sults published earlier. By contrast, it was recently reported
that synthetic GSL-4A could not stimulate mouse or human
iNKT cells (Long et al., 2007). We are not certain why the weak
reactivity to GSL-4A was not observed, but the CD1d-coated
plate assay is highly sensitive, and the A20 B cell transfectants
we used express very high amounts of CD1d. Our results are
consistent, however, with the finding that GSL-4A could not be
processed to GSL-1 because APC lack the enzyme to cleave
the N-glucosamine that GSL-4A contains (Long et al., 2007).
GSL-4B apparently also could not be efficiently processed to
generate GSL-1. GSL-4B does not contain N-glucosamine
and, in addition to glucuronic acid, it has only glucose and galac-
tose sugars that, theoretically, should be subject to lysosomal
processing. We conclude that there must be limitations in the
ability of APC to process carbohydrate antigens, besides the
presence of sugars such as N-glucosamine. The reasons for
this are not known, but it is possible that GSL-4B is not efficiently
transported to lysosomes, or that it does not interact with sapo-
sins or other factors required to generate the final, processed
GSL-1 product.
Although it is the hydrophilic carbohydrate head group that is
exposed for TCR recognition, modifications of the lipid tails of
glycolipid Ags can affect antigenic potency. For example, for
aGalCer, it was shown that truncation of the sphingosine base
in OCH or unsaturation of the acyl chain in C20:2 can influence
not only antigenic strength but also the pattern of cytokine pro-
duction (Miyamoto et al., 2001; Yu et al., 2005). Furthermore,
the antigenic activity of diacylglycerol Ags fromBorrelia burgdor-
feri is strongly influenced by the length of the acyl chains and the
number of unsaturated bonds, as has also been observed for
those iNKT cells that recognize phospholipid Ags (Kinjo et al.,
2006). The recent structure of the trimolecular complex of the
iNKT cell TCR interacting with a complex of aGalCer bound to
human CD1d shows extensive contacts between the TCR and
the top of the a helices of the CD1d molecule (Borg et al.,
2007). As there is evidence that bound lipids can influence the
conformation of these helices (McCarthy et al., 2007; Wu et al.,662 Chemistry & Biology 15, 654–664, July 21, 2008 ª2008 Elsevier2006), it is understandable that the chemical composition of
the buried lipid could influence TCR recognition. Sphingomonas
bacteria synthesize GSL Ags with sphingosine chains that are
mixtures with C20:1 and a cyclopropyl ring containing C21:0
(C21cycl), in addition to C18:0 (Kawahara et al., 1991, 2000,
2002, 2006). We synthesized a GSL containing a C21cycl sphi-
nogsine (GalGSL-C21cycl) and tested its antigenic activity in
two assays. GalGSL-C21cycl induced a substantial amount of
IFNg and IL-4 in serum of mice at 2 hr after injection, and the cy-
tokine pattern was not too different from that induced with
aGalCer, although the response to GalGSL-C21cycl was weaker
and the late IFNg in the serum was decreased proportionately
somewhat more than the IL-4. GalGSL-C21cycl has a galactose
head group, which provides a stronger immune stimulus than an-
tigens containing identical lipids with galacturonic acid (Wu et al.,
2006). Ags with glucuronic acid are even weaker than those with
galacturonic acid (Kinjo et al., 2005). Although GalGSL-C21cycl
shares the same galactose head group as aGalCer, these com-
pounds are not directly comparable, as they have additional dif-
ferences. GalGSL-C21cycl is typical of the ceramide lipids in
Sphingomonas GSLs in that it has a C14 rather than the C26
acyl chain of aGalCer, and it lacks the 4 position hydroxyl in
the sphingosine base. Whereas neither modification by itself
should have a large effect on antigenic potency (Sidobre et al.,
2004; Zajonc et al., 2005), the combined effects of the two
changes could be highly significant. Therefore, although it is
not possible to assess quantitatively the effect of the C21cycl
sphingosine on antigenic potency, the results clearly show that
the F0 pocket of mCD1d, which binds the sphingoid base, can
accommodate a GSL that contains this type of sphingosine to
form an epitope that stimulates iNKT cells. Structural studies
will be required to determine how this longer sphingosine base
fits into the F0 pocket, and how it might affect the orientation of
the exposed a-linked sugar and the induced fit of CD1d that oc-
curs when some GSL Ags bind to it (Koch et al., 2005; McCarthy
et al., 2007; Zajonc et al., 2005).
SIGNIFICANCE
We have shown that the different Sphingomonas GSLs vary
greatly in their ability to activate the invariant TCR of iNKT
cells. As opposed to GSLs containing a single acidic sugar
or galacturonic or glucuronic acid, the oligosaccharide-con-
taining Ags we tested are either not antigenic or only weakly
antigenic. It is possible that the additional sugars in a1-4
linkage to glucuronic acid provide steric hindrance for inter-
action with the iNKT cell TCR. The crystal structure of the
human invariant NKT cell TCR bound to aGalCer CD1d com-
plexes suggests that it would be difficult for the TCR to ac-
commodate additional sugars in the 40 position (Borg et al.,
2007). Moreover, these oligosaccharides are not processed
to generate the much more potent GSL-1 Ag that contains
a single sugar. The reasons for this inefficient processing
are unknown, but they must include factors besides the
presence of a glucosamine sugar, which mammalian cells
cannot efficiently cleave fromGSLs. Therefore, we conclude
that there must be several factors that limit the ability of an-
tigen presenting cells to process and present more complex
glycolipid structures. By contrast to the GSLs withLtd All rights reserved
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was a fairly potent Ag, indicating that the F0 pocket of
mCD1d that binds the sphingosine can accommodate bases
longer than C18:0. We conclude that individual Sphingomo-
nas species synthesize mixtures of strongly antigenic,
weakly antigenic, and nonantigenic glycolipids, based
upon changes in the sugar and/or the lipidmoieties. The bal-
ance of different GSLs synthesized by an individual strain re-
flects culture conditions and likely also reflects conditions in
the environment. Based on this, we speculate that the mod-
ulation of GSL synthesis by Sphingomonas bacteria could
serve as an immune evasion mechanism to avoid the re-
sponses of iNKT cells.
EXPERIMENTAL PROCEDURES
Reagents and Cell Lines
aGalCer, aGal(1-2)aGalCer, and Sphingomonas GSL-1 (previously also called
GSL-10 or GalAGSL) were described previously (Kawano et al., 1997; Kinjo
et al., 2005; Prigozy et al., 2001; Wu et al., 2006). B cell lymphoma A20 cells
were obtained from the American Type Culture Collection (Rockville, MD,
USA). The generation of A20 transfectants expressing wild-type mCD1d or
mCD1d with a single point mutant (I/A) in the cytoplasmic tail were character-
ized previously (Elewaut et al., 2003; Lawton et al., 2005), as were the Va14i
NKT cell hybridomas 1.2 (Vb8.2/Va14i), 2C12 (Vb8.2/Va14i; with a different
CDR3b), and 2H4 (Vb7/Va14i) (Matsuda et al., 2000).
Antigen Presentation Assays
The antigen presentation assay has been described before (Lawton et al.,
2005). Briefly, A20 cells transfected with wild-type or single point mutant
(I/A) mCD1d were used as APC. APC (1 3 106/ml) were pulsed with vehicle
or the indicated amounts of GSL Ags overnight, followed by washing with me-
dium. APC (13 105 per well) were seeded in 96-well plates and cultured in the
presence of 53 104 Va14i NKT cell hybridomas for 20–24 hr. IL-2 release was
evaluated in a sandwich ELISA using rat anti-mouse IL-2 mAbs (BD Biosci-
ences, San Jose, CA, USA).
Cell-Free Antigen Presentation Assay
Stimulation of Va14i NKT cell hybridomas on microwell plates coated with sol-
uble mCD1d was carried out according to published protocols (Naidenko
et al., 1999; Sidobre et al., 2004; Tupin and Kronenberg, 2006), with slight
modifications. Briefly, the indicated amounts of compounds were incubated
for 24 hr in microwells that had been coated with 1.0 mg of mCD1d. After wash-
ing, 5 3 104 to 1 3 105 Va14i NKT hybridoma cells were cultured on the plate
for 20 hr, and IL-2 in the supernatant was measured by ELISA.
Mice and In Vivo Experiments
C57BL/6 mice were from the Jackson Laboratory (Bar Harbor, ME, USA). The
mice were housed under specific pathogen-free conditions and the experi-
ments were approved by the Institutional Animal Care and Use Committee
of the La Jolla Institute of Allergy and Immunology. Mice were injected intrave-
nously with 10 mg of GalGSL-C21cycl, 1 mg of aGalCer, or vehicle (0.025%
Tween 20 in saline). Serum was collected 2 and 16 hr later, and IFNg and
IL-4 in serum were measured by ELISA (BD Biosciences).
SUPPLEMENTAL DATA
Supplemental Data contain one figure, one table, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at http://www.chembiol.com/cgi/content/full/15/7/654/DC1/.
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